查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1878102

全球阻塞設備市場－2025年至2030年預測

Global Occlusion Devices Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球阻塞設備市場預計將從 2025 年的 33.83 億美元成長到 2030 年的 44.23 億美元，複合年成長率為 5.51%。

阻塞是指血管或其他器官的阻塞或閉塞，這是一項重大的臨床挑戰，需要使用專門的醫療技術來解決。阻塞設備在清除此類阻塞、恢復血流或輔助微創手術方面發揮關鍵作用。這些裝置對於治療多種疾病至關重要，包括心血管疾病、婦科疾病和神經系統疾病。由於全球醫療保健環境的多種因素，預計這些裝置的市場將呈現強勁成長。

主要市場成長促進因素

全球阻塞設備市場的擴張主要受患者數量成長的驅動。這一成長與需要解除血管閉塞的各種疾病（尤其是心血管和神經系統疾病）的盛行率上升直接相關。隨著這些疾病在全球範圍內負擔加重，對有效介入治療方法的臨床需求也隨之增加。

推動市場成長的關鍵趨勢之一是全球微創手術的日益普及。這些手術通常使用血管閉塞裝置，與傳統開放性手術相比，能為患者帶來顯著優勢，例如創傷更小、住院時間更短、恢復更快。手術方式的轉變是推動先進血管閉塞技術應用的主要因素。此外，針對這些微創手術的有利報銷政策的建立和完善，提高了患者獲得治療的機會，從而顯著促進了市場成長。臨床療效、患者對微創治療的需求以及有利的支付框架共同構成了血管閉塞裝置市場強勁的成長引擎。

市場限制

儘管市場呈現成長態勢，但仍存在諸多限制限制其擴張。其中一個關鍵挑戰是醫療設備認證的嚴格監管環境。獲得阻塞設備的市場核准通常十分複雜、耗時且成本高昂，需要大量的臨床數據來證明其安全性和有效性。這種嚴格的核准途徑導致產品上市延遲，並增加了製造商的研發成本。

進一步加劇這項挑戰的是，熟練這些先進設備操作技能的專業人員普遍短缺。有效部署血管閉塞裝置通常需要專門訓練和進階操作技能。由於合格操作人員的配備是使用這些先進醫療設備的先決條件，因此，熟練臨床醫生的短缺可能會限制新技術的普及率並抑制市場成長。

調查方法與市場情報框架

本分析全面檢驗了目前閉塞裝置的市場格局，分析了與需求、供應、銷售和近期產業發展相關的趨勢。報告旨在透過識別和評估影響產業發展軌蹟的關鍵促進因素、阻礙因素和機遇，全面整體情況市場環境。

本研究的關鍵組成部分是對法規環境和區域格局的詳細分析，包括對各地區行業動態、趨勢以及現行政策法規的深入審查。了解這個全面的法規結構對相關人員至關重要，因為它能提供對產業產生重大影響的因素（例如合規要求和市場准入障礙）的關鍵洞察。

透過廣泛的二手資料研究，我們評估了競爭格局，以確定主要行業參與者並評估其對整體市場及相關細分市場的收入貢獻。資訊收集過程利用了多種來源，例如產業協會發布的各類調查和數據、分析師報告、企業投資者報告、資訊來源、學術期刊等。

我們的市場規模調查方法採用嚴謹的兩階段流程。我們同時運用自下而上和自上而下的分析方法來評估整體市場及其關鍵細分市場的規模。然後，我們將這些計算得出的數據與全球封堵器價值鏈中主要相關人員的原始數據進行比對，以確保其與實際市場情況相符。

我們分析的最後階段是全面的市場工程，這包括將來自不同資訊來源的資料與現有的專有資料集進行整合。為了確保準確性和可靠性，我們對市場區隔和預測都採用了多種資料三角驗證技術，從而得出穩健且檢驗的市場展望。

我們透過詳細的分析、圖表和圖形來呈現市場訊息，旨在幫助我們的客戶更快、更有效地了解全球閉塞裝置市場，並幫助他們根據清晰、易於獲取的數據做出戰略決策。

市場格局由幾家成熟的醫療技術領導企業主導。本次全面的市場分析重點介紹了Terumo Corporation NV)、雅培 (Abbott) 和美Medtronic)等主要企業。了解這些公司的策略、產品系列和市場地位對於理解阻塞設備產業的競爭動態和未來發展方向至關重要。這些成熟企業的存在凸顯了市場的成熟度，以及為滿足不斷變化的臨床需求和應對複雜的法規環境而持續創新的必要性。

本報告的主要優勢：

  • 深入分析：獲得主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局：了解全球主要企業的策略舉措，並了解透過正確的策略進入市場的可能性。
  • 市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議：利用這些見解，在快速變化的環境中製定策略決策，發展新的商業機會和收入來源。
  • 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

企業使用我們的報告的目的是什麼？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

  • 2022年至2024年的歷史數據和2025年至2030年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區分類的收入成長和預測評估，包括國家/地區
  • 公司概況（策略、產品、財務資訊、關鍵發展等）

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍

第2章 4. 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 全球阻塞設備市場（依類型分類）

  • 介紹
  • 堵塞清除劑
  • 栓塞治療裝置
  • 輸卵管阻塞設備

6. 全球阻塞設備市場（依應用分類）

  • 介紹
  • 心臟病學
  • 婦科
  • 神經病學
  • 泌尿系統
  • 其他

7. 全球阻塞設備市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 門診手術中心

8. 全球阻塞設備市場（依地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章：競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Abbott
  • Penumbra, Inc.
  • Medtronic
  • AtriCure, Inc.
  • Terumo Europe NV
  • Neuravi
  • Prytime Medical Devices, Inc
  • Acrostak Int.
  • ArtVentive Medical Group, Inc.
  • EndoShape, Inc

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061611891

The global occlusion devices market is projected to rise at a 5.51% CAGR, achieving USD 4.423 billion in 2030 from USD 3.383 billion in 2025.

Occlusion, defined as the blockage or closure of a blood vessel or other bodily organ, represents a significant clinical challenge addressed by specialized medical technology. Occlusion devices are instrumental in removing such blockages to restore blood flow or facilitate minimally invasive surgical procedures. These devices are critical in treating a range of conditions, including cardiovascular, gynecological, and neurological defects. The market for these devices is projected to demonstrate robust growth, driven by several converging factors within the global healthcare landscape.

Primary Market Growth Drivers

The expansion of the occlusion devices market is largely attributable to a growing patient population worldwide. This increase is directly linked to the rising prevalence of various disorders that necessitate occlusion removal, particularly in the cardiovascular and neurological domains. As the global burden of these diseases increases, so does the clinical demand for effective interventional solutions.

A pivotal trend accelerating market growth is the rising global adoption of minimally invasive surgeries. These procedures, which often utilize occlusion devices, offer significant patient benefits over traditional open surgery, including reduced trauma, shorter hospital stays, and faster recovery times. This shift in surgical preference is a major driver for the adoption of advanced occlusion technologies. Furthermore, the establishment and evolution of favorable reimbursement policies for such minimally invasive procedures are making these treatments more accessible to patients, thereby providing a substantial boost to the market. The combination of clinical efficacy, patient demand for less invasive options, and supportive payment frameworks creates a powerful growth engine for the occlusion devices sector.

Market Restraints

Despite the positive growth trajectory, the market faces notable constraints that could temper its expansion. A significant challenge is the stringent regulatory environment governing the approval of medical devices. The process for gaining market authorization for occlusion devices is often complex, time-consuming, and costly, requiring extensive clinical data to demonstrate safety and efficacy. This rigorous pathway can delay product launches and increase development expenses for manufacturers.

Compounding this challenge is a widespread lack of trained and skilled professionals proficient in the use of these advanced devices. The effective deployment of occlusion devices often requires specialized training and a high degree of procedural expertise. A shortage of such skilled clinicians can limit the adoption rate of new technologies and restrain market growth, as the availability of qualified operators is a prerequisite for the utilization of these sophisticated medical tools.

Research Methodology and Market Intelligence Framework

This analysis provides a comprehensive examination of the current occlusion devices market landscape, scrutinizing trends related to demand, supply, sales, and recent industry developments. The report is structured to deliver an exhaustive picture of the market environment by identifying and evaluating the major drivers, restraints, and opportunities that are influencing the industry's trajectory.

A critical component of the study involves a detailed analysis of the regulatory and regional landscape. This encompasses an in-depth review of industry developments, trends, and the specific policies and regulations implemented across various geographical regions. Understanding this overarching regulatory framework is essential for stakeholders, as it provides critical insight into the compliance requirements and market entry barriers that significantly impact the industry.

The competitive landscape has been assessed through extensive secondary research designed to identify key industry players and evaluate their revenue contribution to the overall market and relevant segments. This intelligence-gathering process incorporates a wide array of sources, including various studies and data published by industry associations, analyst reports, company investor presentations, press releases, and academic journals.

The methodology for determining market size employs a rigorous, dual-pronged approach. Both bottom-up and top-down analytical techniques are utilized to calculate the size of the overall market and its key segments. The values derived from these calculations are subsequently correlated with primary inputs obtained from key stakeholders operating across the global occlusion devices value chain, ensuring alignment with real-world market conditions.

The final phase of the analysis involves comprehensive market engineering. This process integrates data from diverse sources and existing proprietary datasets. To ensure accuracy and reliability, various data triangulation methods are applied for both market breakdown and forecasting, resulting in a robust and validated market outlook.

The resulting market intelligence is presented through detailed analysis, charts, and graphics. This format is designed to facilitate a faster and more efficient understanding of the global occlusion devices market for clients, enabling strategic decision-making based on clear, accessible data.

The market landscape features several established medical technology leaders. Major players profiled as part of the comprehensive market analysis include Terumo Europe NV, Abbott, and Medtronic, among others. The strategies, product portfolios, and market positions of these companies are integral to understanding the competitive dynamics and future direction of the occlusion devices industry. The presence of such well-established participants underscores the market's maturity and the continuous innovation required to meet evolving clinical needs and navigate the complex regulatory environment.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

  • GLOBAL OCCLUSION DEVICES MARKET BY TYPE
  • Occlusion Removal Devices
  • Embolization Devices
  • Tubal Occlusion Devices
  • GLOBAL OCCLUSION DEVICES MARKET BY APPLICATION
  • Cardiology
  • Gynaecology
  • Neurology
  • Urology
  • Others
  • GLOBAL OCCLUSION DEVICES MARKET BY END-USERS
  • Hospitals
  • Ambulatory SurgIcal Centers
  • GLOBAL OCCLUSION DEVICES MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL OCCLUSION DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Occlusion Removal Devices
  • 5.3. Embolization Devices
  • 5.4. Tubal Occlusion Devices

6. GLOBAL OCCLUSION DEVICES MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cardiology
  • 6.3. Gynaecology
  • 6.4. Neurology
  • 6.5. Urology
  • 6.6. Others

7. GLOBAL OCCLUSION DEVICES MARKET BY END-USERS

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory SurgIcal Centers

8. GLOBAL OCCLUSION DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott
  • 10.2. Penumbra, Inc.
  • 10.3. Medtronic
  • 10.4. AtriCure, Inc.
  • 10.5. Terumo Europe NV
  • 10.6. Neuravi
  • 10.7. Prytime Medical Devices, Inc
  • 10.8. Acrostak Int.
  • 10.9. ArtVentive Medical Group, Inc.
  • 10.10. EndoShape, Inc

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations